[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341368-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341368-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","circrnas-in-endometrial-cancera-promising-biomarker-state-of-the-art","circRNAs in Endometrial Cancer—A Promising Biomarker - State of the Art","","Endometrial cancer (EC) is a leading malignant tumor among women and its mortality continues to rise, while current diagnosis relies on biopsy and is invasive, painful, and sometimes risky. A new non-invasive biomarker is needed to support both early detection and treatment decisions. Circular RNAs (circRNAs) are stable, covalently closed non-coding RNA molecules abundant in body fluids and tissues, with emerging roles in EC. This review synthesizes molecular division aspects, biogenesis, functions, and diagnostic and clinical relevance of circRNAs.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/circrnas-in-endometrial-cancera-promising-biomarker-state-of-the-art/341368/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/circrnas-in-endometrial-cancera-promising-biomarker-state-of-the-art/341368.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is a new biomarker needed for endometrial cancer diagnosis?","Question",{"text":63,"@type":64},"Current EC diagnosis depends on biopsy and histopathological examination, which is invasive and can cause pain, discomfort, or complications. A non-invasive biomarker could improve speed and ease of diagnosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What are circRNAs and why are they relevant to endometrial cancer?",{"text":68,"@type":64},"circRNAs are small, covalently closed, stable non-coding RNAs found in body fluids and human tissues. They are expressed in various ways and are linked to molecular mechanisms in EC.",{"name":70,"@type":61,"acceptedAnswer":71},"What does this review focus on regarding circRNAs in EC?",{"text":72,"@type":64},"The review emphasizes the molecular aspects of EC classification/division and summarizes circRNA biogenesis and functions, as well as their diagnostic and clinical significance in EC.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341368,1790160855,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":118,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":104,"preview_page_count":33,"preview_urls":145},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Review  \ncircRNAs in Endometrial Cancer—A Promising Biomarker: State of the Art  \nKarolina Włodarczyk 1, *, Weronika Kuryło 1, Anna Pawłowska-Łachut 1, Wiktoria Skiba 1, Dorota Suszczyk 1, Paulina Pienia˛dz 1,2, Małgorzata Majewska 3, Ewa Boniewska-Bernacka 4 and Iwona Wertel 1  \nCitation: Włodarczyk, K.; Kuryło, W.; Pawłowska-Łachut, A.; Skiba, W.; Suszczyk, D.; Pienia˛dz, P.; Majewska, M.; Boniewska-Bernacka, E.; Wertel, I.  \ncircRNAs in Endometrial Cancer—A Promising Biomarker: State of the Art.  \nInt. J. Mol. Sci. 2024, 25, 6387. [https://](https://)[ ](https://)[doi.org/10.3390/ijms25126387](doi.org/10.3390/ijms25126387)  \nAcademic Editors: Urszula Oleksiewicz and Andrzej Mackiewicz  \nReceived: 30 April 2024  \nRevised: 2 June 2024  \nAccepted: 6 June 2024  \nPublished: 9 June 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Independent Laboratory of Cancer Diagnostics and Immunology, Department of Oncological Gynaecology and Gynaecology, Faculty of Medicine, Medical University of Lublin, Chod´zki 1, 20-093 Lublin, Poland; [weronikakurylo@student.umlub.pl](weronikakurylo@student.umlub.pl) (W.K.); [anna.pawlowska@umlub.pl](anna.pawlowska@umlub.pl) (A.P.-Ł.);  \n[wiktoria.skiba@umlub.pl](wiktoria.skiba@umlub.pl) (W.S.); [dorota.suszczyk@umlub.pl](dorota.suszczyk@umlub.pl) (D.S.); [paulina.pieniadz@umlub.pl](paulina.pieniadz@umlub.pl) (P.P.);  \n[iwona.wertel@umlub.pl](iwona.wertel@umlub.pl) (I.W.)  \n2 Department of Virology and Immunology, Institute of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka 19, 20-031 Lublin, Poland  \n3 Department of Industrial and Environmental Microbiology, Institute of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka 19, 20-031 Lublin, Poland; [malgorzata.majewska@mail.umcs.pl](malgorzata.majewska@mail.umcs.pl)  \n[4](4 Medical Department)[ Medical Department](4 Medical Department), [Institute of Medical Sciences](Institute of Medical Sciences), [University of Opole](University of Opole), [Oleska 48](Oleska 48), [45-052 Opole](45-052 Opole), [Poland](Poland); [boniesia@uni.opole.pl](boniesia@uni.opole.pl)  \n* Correspondence: [karolina.wlodarczyk@umlub.pl](karolina.wlodarczyk@umlub.pl)  \nAbstract: Endometrial cancer (EC) is one of the most common malignant tumors among women in the 21st century, whose mortality rate is increasing every year. Currently, the diagnosis of EC is possible only after a biopsy. However, it is necessary to find a new biomarker that will help in both the diagnosis and treatment of EC in a non-invasive way. Circular RNAs (circRNAs) are small, covalently closed spherical and stable long non-coding RNAs (lncRNAs) molecules, which are abundant in both body fluids and human tissues and are expressed in various ways. Considering the new molecular classification of EC, many studies have appeared, describing new insights into the functions and mechanisms of circRNAs in EC. In this review article, we focused on the problem of EC and the molecular aspects of its division, as well as the biogenesis, functions, and diagnostic and clinical significance of circRNAs in EC.  \nKeywords: circRNA; biogenesis of circRNAs; function of circRNAs; endometrial cancer; biomarker  \n1. Introduction  \nEndometrial cancer (EC) is the most common gynecologic cancer and the sixth most common malignancy in women worldwide after breast, lung, colorectum, cervix uteri, and thyroid cancers. According to the World Health Organization (WHO), in 2022, as many as 420,368 women were diagnosed with endometrial cancer, and unfortunately, this malignancy caused 97,723 deaths [1] . The highest cancer rates are observed in North America (73,977 new cases) and Eu","cbCailYnYPS3NhNV","https://ap.wps.com/l/cbCailYnYPS3NhNV","pdf",708732,"English","# 1. Introduction\n## Endometrial cancer burden and diagnostic limitations\n## Need for non-invasive biomarkers\n# Abstract\n# Keywords","[{\"question\":\"Why is a new biomarker needed for endometrial cancer diagnosis?\",\"answer\":\"Current EC diagnosis depends on biopsy and histopathological examination, which is invasive and can cause pain, discomfort, or complications. A non-invasive biomarker could improve speed and ease of diagnosis.\"},{\"question\":\"What are circRNAs and why are they relevant to endometrial cancer?\",\"answer\":\"circRNAs are small, covalently closed, stable non-coding RNAs found in body fluids and human tissues. They are expressed in various ways and are linked to molecular mechanisms in EC.\"},{\"question\":\"What does this review focus on regarding circRNAs in EC?\",\"answer\":\"The review emphasizes the molecular aspects of EC classification/division and summarizes circRNA biogenesis and functions, as well as their diagnostic and clinical significance in EC.\"}]","circRNAs in Endometrial Cancer—A Promising Biomarker - State of the Art | PDF",1790041663,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb7a6e71a6481c291843404f752fbde7.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8829418cdb7d7407a3ea044a3e9cd7c.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de4c810e736be3081bdb6111efc3ebad.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6443f3ae0f906631ff933883f959cba.webp",980,1385]